Mankind Pharma commences commercial operations at Udaipur plant

Mankind Pharma Limited has announced that the commercial operations with respect to pharmaceutical formulations has commenced at the company's newly set-up plant in Udaipur, Rajasthan with effect from September 25, 2023.

Sequent Scientific gets Form 483 with One Observation from USFDA for Vizag facility

The United States Food and Drug Administration (USFDA) had an inspection of Sequent Scientific Limited's manufacturing facility situated at Visakhapatnam, Andhra Pradesh from September 18, 2023 to September 22, 2023. At the end of the inspection, we have been issued a Form 483 with one observation. The observation is procedural in nature. We will respond to the USFDA within the stipulated timeline and work closely with them to address the observation at the earliest. The Company remains committed to maintaining the highest standards of quality, safety and compliance.